Keywords: دابیگاتران ; AF; SPAF; Dabigatran; Rivaroxaban; Apixaban;
مقالات ISI دابیگاتران (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: دابیگاتران ; Atrial fibrillation; Stroke; Dabigatran; Rivaroxaban; Thrombolysis
Keywords: دابیگاتران ; dabigatran; intracerebral hemorrhage; anticoagulation reversal; FEIBA; ischemic stroke;
Keywords: دابیگاتران ; Thrombolysis; anticoagulation; stroke; dabigatran; thrombin time; partial thromboplastin time;
Keywords: دابیگاتران ; Aspirin; Apixaban; Dabigatran; Edoxaban; Rivaroxaban; Oral anticoagulants; Pulmonary embolism; Venous thromboembolism; Venous thrombosis
Keywords: دابیگاتران ; Pulmonary vein; Thrombosis; 64-MDCT; Dabigatran
Keywords: دابیگاتران ; Venous thromboembolism; Cancer; New oral anticoagulants; Apixaban; Dabigatran; Rivaroxaban; Edoxaban
Keywords: دابیگاتران ; Venous thromboembolism; Dabigatran; Rivaroxaban; Apixaban; Edoxaban; Warfarin;
Keywords: دابیگاتران ; Bleeding; Safety; Dabigatran; Rivaroxaban; Apixaban; Prothrombin complex concentrates;
Keywords: دابیگاتران ; Dabigatran; Apixaban; Rivaroxaban; Traveller's thrombosis; Anticoagulation
Keywords: دابیگاتران ; Atrial fibrillation; Stroke; Dabigatran; Rivaroxaban; Apixaban; Edoxaban;
Keywords: دابیگاتران ; apixaban; bleeding; dabigatran; direct oral anticoagulant; edoxaban; management; pharmacology; rivaroxaban; ACS; acute coronary syndrome; AF; atrial fibrillation; ASA; acetylsalicylic acid; bid; twice daily; CrCl; creatinine clearance; CYP; cytochrome P45
Keywords: دابیگاتران ; Dabigatran; Rivaroxaban; Apixaban;
Keywords: دابیگاتران ; anticoagulant; dabigatran; rivaroxaban; bleeding; antidote;
Keywords: دابیگاتران ; Dabigatran; anticoagulant; ischemic stroke; intracerebral hemorrhage; pharmacokinetics; renal function
Keywords: دابیگاتران ; ADP receptor antagonists; dabigatran; fondaparinux; glycoprotein IIb/IIIa antagonists; heparin; rivaroxaban; warfarin
Keywords: دابیگاتران ; Novel oral anticoagulants; Atrial fibrillation; Warfarin; Dabigatran; RivaroxabanAF, atrial fibrillation; CHADS2, cardiac failure, hypertension, age, diabetes, stroke (doubled); CHA2DS2-VASc, congestive heart failure, hypertension, age ≥75 years (doubled)
Use of Idarucizumab for dabigatran reversal: Emergency department experience in two cases with subdural haematoma
Keywords: دابیگاتران ; Idarucizumab; Dabigatran; Intracranial haemorrhage; Wounds and injuries; Emergency department;
Ãpistaxis compliquant un traitement par anti-vitamine K et nouveaux anticoagulants oraux
Keywords: دابیگاتران ; Ãpistaxis; Rivaroxaban; Dabigatran; Anticoagulants oraux;
Epistaxis complicating treatment by anti-vitamin K and new oral anticoagulants
Keywords: دابیگاتران ; Epistaxis; Rivaroxaban; Dabigatran; Oral anticoagulants;
Dabigatran Reversal in a Patient With End-Stage Liver Disease and Acute Kidney Injury
Keywords: دابیگاتران ; Dabigatran; end-stage liver disease (ESLD); acute kidney injury (AKI); thrombin inhibitor; oral anticoagulant; renal clearance; hemorrhage; bleeding; dose adjustment; drug safety; decreased kidney function; idarucizumab;
Point of Care Testing (POCT) to assess drug concentration in patients treated with non-vitamin K antagonist oral anticoagulants (NOACs)
Keywords: دابیگاتران ; Apixaban; Concentration; Dabigatran; Emergency; Point of Care Test; Rivaroxaban;
Use of DOAC Stop for elimination of anticoagulants in the thrombin generation assay
Keywords: دابیگاتران ; Thrombin generation assay; Direct oral anticoagulants; DOAC adsorbent; Dabigatran; Rivaroxaban; Edoxaban; Apixaban;
Basic coagulation tests as surrogates of dabigatran levels in a pre-operative setting: Analysis of five activated partial thromboplastin time reagents and thrombin time
Keywords: دابیگاتران ; Dabigatran; Oral anticoagulant; Partial thromboplastin time; Blood coagulation tests; Surgery;
Simple method for removing DOACs from plasma samples
Keywords: دابیگاتران ; DOAC; Dabigatran; Apixaban; Rivaroxaban; Edoxaban; APTT; dRVVT; Lupus anticoagulant; Clotting tests; DOAC adsorbent;
The effect of dabigatran on thrombin generation and coagulation assays in rabbit and human plasma
Keywords: دابیگاتران ; Coagulation assays; Dabigatran; Ecarin clotting time; LC-MS/MS; Thrombin generation;
The safety and efficacy of non-vitamin K antagonist oral anticoagulants in atrial fibrillation in the elderly
Keywords: دابیگاتران ; Apixaban; Atrial fibrillation; Dabigatran; Non-vitamin K antagonist oral anticoagulant; Edoxaban; Rivaroxaban;
Idarucizumab-facilitated intravenous thrombolysis in acute ischemic stroke: A therapeutic strategy requiring further investigation
Keywords: دابیگاتران ; Hemorrhagic transformation; Idarucizumab; Thrombolysis; Dabigatran; Ischemic stroke;
Comprehensive characteristics of the anticoagulant activity of dabigatran in relation to its plasma concentration
Keywords: دابیگاتران ; APTT; activated partial thromboplastin time; APTT-Cepha; APTT using Cephascreen® (Diagnostica Stago) reagent; APTT-PSL; APTT using Pathromtin®SL (Siemens Healthcare) reagent; ANOVA; analysis of variance; CAT; calibrated automated thrombinography; CT; cl
Analysis of Recurrent Stroke Volume and Prognosis between Warfarin and Four Non-Vitamin K Antagonist Oral Anticoagulants' Administration for Secondary Prevention of Stroke
Keywords: دابیگاتران ; Stroke volume; recurrent; NOAC; DOAC; direct thrombin inhibitor; dabigatran; factor Xa inhibitor; rivaroxaban; apixaban; edoxaban; warfarin;
Bleeding in advanced CKD patients on antithrombotic medication - A critical appraisal
Keywords: دابیگاتران ; acetylsalicylic acid; clopidogrel; prasugrel; ticagrelor; dabigatran; rivaroxaban; apixaban; warfarin; heparin; low molecular weight heparin; proton pump inhibitors; Bleeding; Chronic kidney disease; Management; Risk;
Thrombin induces protease-activated receptor 1 signaling and activation of human atrial fibroblasts and dabigatran prevents these effects
Keywords: دابیگاتران ; Thrombin; Protease-activated receptor 1; Fibroblast; Dabigatran; Atrial fibrillation;
What have we learned from real-world NOAC studies in venous thromboembolism treatment?
Keywords: دابیگاتران ; Real world evidence; Apixaban; Dabigatran; Edoxaban; Rivaroxaban; Venous thromboembolism;
Measurement of apixaban, dabigatran, edoxaban and rivaroxaban in human plasma using automated online solid-phase extraction combined with ultra-performance liquid chromatography-tandem mass spectrometry and its comparison with coagulation assays
Keywords: دابیگاتران ; aPTT; activated partial thromboplastin time; BEH; bridged ethyl hybrid; CV; coefficient of variation; DOACs; direct oral anticoagulants; DTI; direct thrombin inhibitor(s); IS; internal standard; MRM; multiple reaction monitoring mode; MS/MS; tandem mass s
Reversal of dabigatran by intraosseous or intravenous idarucizumab in a porcine polytrauma model
Keywords: دابیگاتران ; anticoagulants; idarucizumab; dabigatran; intraosseous; thromboelastography;
Dabigatran etexilate in the treatment of localized intravascular coagulopathy associated with venous malformations
Keywords: دابیگاتران ; Direct oral anticoagulants; Dabigatran; Intravascular coagulopathy; Vascular malformation;
Management of bleeding and emergency invasive procedures in patients on dabigatran: Updated guidelines from the French Working Group on Perioperative Haemostasis (GIHP) -Â September 2016
Keywords: دابیگاتران ; Dabigatran; Emergency; Dabigatran concentration; Antidote; Bleeding; Surgery;
QCM-D surpassing clinical standard for the dose administration of new oral anticoagulant in the patient of coagulation disorders
Keywords: دابیگاتران ; Dabigatran; Coagulation disorders; Patient plasma; aPTT; PiCT; QCM-D;
The anticoagulant effect of dabigatran is reflected in the lag time and time-to-peak, but not in the endogenous thrombin potential or peak, of thrombin generation
Keywords: دابیگاتران ; Anticoagulant; Dabigatran; Idarucizumab; Thrombin generation;
Dabigatran reduces endothelial permeability through inhibition of thrombin-induced cytoskeleton reorganization
Keywords: دابیگاتران ; Dabigatran; Thrombin; Endothelial permeability; Actin cytoskeleton; Myosin light chain;
Effectiveness and safety of dabigatran versus warfarin in “real-world” Japanese patients with atrial fibrillation: A single-center observational study
Keywords: دابیگاتران ; Atrial fibrillation; Dabigatran; Japanese; Stroke; Warfarin;
Non-vitamin K antagonist oral anticoagulants and the management of bleeding
Keywords: دابیگاتران ; Apixaban; bleeding; dabigatran; edoxaban; NOAC; rivaroxaban;
Safety of low-dose dabigatran in patients with atrial fibrillation and mild renal insufficiency
Keywords: دابیگاتران ; Atrial fibrillation; Chronic kidney disease; Anticoagulation; Dabigatran;
Full Length ArticleReversal of dabigatran-associated major bleeding with activated prothrombin concentrate: A prospective cohort study
Keywords: دابیگاتران ; Dabigatran; Bleeding; Activated prothrombin complex concentrate; Atrial fibrillation;
Influence of proton pump inhibitors on blood dabigatran concentrations in Japanese patients with non-valvular atrial fibrillation
Keywords: دابیگاتران ; Dabigatran; Proton pump inhibitor; Drug-drug interaction;
Adjuncts to Blood Component Therapies for the Treatment of Bleeding in the Intensive Care Unit
Keywords: دابیگاتران ; Antifibrinolytics; Apixaban; Bleeding; Dabigatran; Factor concentrates; Factor VIIa; Fibrinogen; Hemorrhage; Prothrombin complex concentrates; Rivaroxaban;
Major bleeding with vitamin K antagonists or direct oral anticoagulants in real-life
Keywords: دابیگاتران ; Anticoagulants; Major bleeding; Intracranial hemorrhage; Dabigatran; Rivaroxaban; Apixaban;
Factor Eight Inhibitor Bypassing Agent (FEIBA) for Reversal of Target-Specific Oral Anticoagulants in Life-Threatening Intracranial Bleeding
Keywords: دابیگاتران ; FEIBA; target-specific oral anticoagulants; life-threatening bleeding; dabigatran; rivaroxaban; apixaban; intracranial hemorrhage; anti-xa inhibitor; anticoagulation; reversal;
Permanent discontinuation of non vitamin K oral anticoagulants in real life patients with non-valvular atrial fibrillation
Keywords: دابیگاتران ; Dabigatran; Rivaroxaban; Apixaban; Atrial fibrillation; Discontinuation; Anticoagulants;
Full Length ArticleWhole blood coagulation assays ROTEM and T-TAS to monitor dabigatran treatment
Keywords: دابیگاتران ; Atrial fibrillation; Dabigatran; Drug monitoring; Flow chamber system; Thromboelastography;